Protein accumulations do important work in the human body, but something can go wrong and proliferate in those aggregates, ...
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...
The ‘NLRP3 inflammasome’ is like a control switch. In Alzheimer’s disease, its activation triggers an inflammatory response ...
When people have Alzheimer’s disease, their brains slowly accumulate abnormal clumps of two proteins: amyloid and tau. At ...
The growth of the Alzheimer's Disease Therapeutics Market is directly influenced by the increasing prevalence of Alzheimer's disease globally. The hi ...
A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...
Lecanemab has given us more years together. That’s not ‘minute’ nor ‘minimal’ to me,” writes one reader in STAT’s letters to ...
A growing body of research suggests that infections, including those caused by common bacteria in gum disease, could ...
Recent research links Alzheimer's disease to bacterial gum infections, specifically the pathogen Porphyromonas gingivalis.
In recent years, a growing number of scientific studies have backed an alarming hypothesis: Alzheimer's disease isn't just a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback